Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

Jessica A. Fowler, Seint T. Lwin, Matthew T. Drake, James R. Edwards, Robert A. Kyle, Gregory R. Mundy, Claire M. Edwards

Blood (2011) 118 (22): 5872–5882.

https://doi.org/10.1182/blood-2011-01-330407

Published: 2011

Includes: Supplemental data

Journal Articles

Osteoclasts in Myeloma Are Derived from Gr-1 + CD11b + Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo

Junling Zhuang, M.D., Ph.D., Li Yang, Ph.D., Seint T Lwin, B.S., Claire M. Edwards, PhD, BSc, James R Edwards, Ph.D., Gregory R Mundy, M.D.

Blood (2008) 112 (11): 736.

https://doi.org/10.1182/blood.V112.11.736.736

Published: 2008

Journal Articles

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Claire M. Edwards, James R. Edwards, Seint T. Lwin, Javier Esparza, Babatunde O. Oyajobi, Brandon McCluskey, Steven Munoz, Barry Grubbs, Gregory R. Mundy

Blood (2008) 111 (5): 2833–2842.

https://doi.org/10.1182/blood-2007-03-077685

Published: 2008

Journal Articles

Protein Profiling in Myeloma In Vivo ; Effects of Bortezomib in a Mouse Model of Myeloma.

Claire M. Edwards, PhD, Robert L. Caldwell, PhD, Andreia L. Bates, Jessica A. Fowler, James R. Edwards, PhD, Babatunde O. Oyajobi, MD, PhD, Seint T. Lwin, Jianghong Zhang, PhD, Gregory R. Mundy, MD

Blood (2007) 110 (11): 255.

https://doi.org/10.1182/blood.V110.11.255.255

Published: 2007

Journal Articles

Targeting Wnt Signaling in Myeloma In Vivo ; Differential Effects on Tumor Burden and Myeloma Bone Disease.

Claire M. Edwards, PhD, James R. Edwards, PhD, Seint T. Lwin, Gregory R. Mundy, MD

Blood (2007) 110 (11): 812.

https://doi.org/10.1182/blood.V110.11.812.812

Published: 2007

NARROW

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

Osteoclasts in Myeloma Are Derived from Gr-1 + CD11b + Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Protein Profiling in Myeloma In Vivo ; Effects of Bortezomib in a Mouse Model of Myeloma.

Targeting Wnt Signaling in Myeloma In Vivo ; Differential Effects on Tumor Burden and Myeloma Bone Disease.

Email alerts

ASH Publications

American Society of Hematology

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

Osteoclasts in Myeloma Are Derived from Gr-1 + CD11b + Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Protein Profiling in Myeloma In Vivo ; Effects of Bortezomib in a Mouse Model of Myeloma.

Targeting Wnt Signaling in Myeloma In Vivo ; Differential Effects on Tumor Burden and Myeloma Bone Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only